Skip to content

Earnings call

Emami Q4 FY25 earnings call: Emami expects its market shares and household penetration across brands to support sustained growth in FY ‘26

By . Assembled by software from the company's transcript. Not reviewed by a person.

Transcript filed .

The company expects its market shares and household penetration across brands to support sustained growth in FY ‘26. Healthcare portfolio grew by 13% annualized in FY 2025, led by several categories. The company relaunched Smart and Handsome with a 360° plan that included changing the brand name, aggressive marketing and a go-to-market strategy in Q4. Pain management contributes around 20% of Emami’s overall revenues.

The numbers management gave

Results

  • Healthcare portfolio grew by 13% annualized in FY 2025, led by several categories.
    Show source
    Gul Raj Bhatia: So I think we have done fairly well in the healthcare portfolio, as indicated by Mr. Mohan ji, where they grew by 13% annualized.
  • Zanducare, Emami’s D2C portfolio, grew nearly 50% in FY 2025, driven by new product launches, marketing initiatives, better return on marketing investment and stronger product-benefit and efficacy claims.
    Show source
    One was the D2C portfolio Zanducare, which had a growth of nearly 50%, and it was led both by new product launches and various initiatives led by crude marketing, better return on investments in the marketing space, and also more aggressive claims in terms of our product benefits and efficacy.
  • Nityam, Cough Syrup and hair juices grew in strong double digits in FY 2025.
    Show source
    On brands like Nityam, brands like Cough Syrup where we grew in strong double digits along with the hair juices also.
  • Medico business, which reaches out to doctors, had good growth in the fourth quarter and in FY 2025.
    Show source
    And on the medico business, which we reach out to doctors for, we had good growth there also, both in quarter four and for the whole year.
  • The company had done more than Rs. 690 crores of advertising this year and said it would continue with that level this year.
    Show source
    We have done almost I think more than Rs. 690 crores of advertising this year, which is quite significant.
  • The company generated around 4% of revenue from products launched in the last two to three years.
    Show source
    Rajesh Sharma: So roughly it is around 4% kind of revenue what we have generated from the products launched in last two to three years.
Show 8 more statements

Results

  • Brillare and The Man Company showed early signs of recovery in certain channels and categories in April and May.
    Show source
    And we are already seeing some green shoots when we look at certain channels and certain categories in the month of April and May.
  • Zandu Ultra Power and Mentho Plus Pain Balm have consistently grown, while Zandu Balm’s green pack, the main product, is showing signs of stress.
    Show source
    Ultra Power and Mentho Plus has consistently been growing, but unfortunately the green pack, which is the main product, is showing signs of some stress.
  • The company has arrested the decline in Smart and Handsome.
    Show source
    Smart and Handsome, the decline has been arrested.
  • Secondary sales were slightly lower because of rains after the company made some primaries in Q4.
    Show source
    We had of course done some primaries in Q4 , so the secondaries are slightly on the lower side because of rains.
  • The company saw a rebound in Bangladesh in Q4 and delivered very good numbers there in February and March.
    Show source
    But Q4 we had seen a rebound , then we were still okay, February, March, we delivered very good numbers over there.
  • The company said GCC was showing signs of growth.
    Show source
    GCC is still showing some signs of the growth and everything.
  • The company said Russia CIS was decent for its business.
    Show source
    Russia CIS is also decent for us.
  • The company said one or two countries in Africa were its only places of trouble, while it was seeing growth numbers in more places overall.
    Show source
    The only place of trouble is one or two countries in Africa which are decent for us, but by and large more places we are seeing more growth numbers over here.

What it expects ahead

What management expects

  • The company expects its market shares and household penetration across brands to support sustained growth in FY ‘26.
    Show source
    Our market shares and household penetration across brands are trending upwards, giving us confidence of sustaining growth in FY ‘26.
  • The company anticipates positive momentum in FY ‘26 for male grooming, Kesh King and The Man Company following strategic actions.
    Show source
    With strategic actions being taken for male grooming, range Kesh King and The Man Company, we anticipate positive momentum for these brands in FY ‘26.
  • The company anticipated robust, all-round growth in FY26 ('26) as its international business and strategic investments were poised for a rebound, showing signs of rebound.
    Show source
    With our international business and strategic investments showing promising signs of rebound, we are excited about delivering robust all- round growth in FY ‘26.
  • The company is looking forward to high double-digit growth in FY ‘26 for Brillare and The Man Company, with significant investment in both businesses to build their brand franchises, especially the top of the funnel.
    Show source
    So when we look at FY ‘26, both for Brillare as well as for TMC, we are looking forward to a high double-digit growth in both these businesses.
  • The company expects 5% to 6% growth in categories other than pain management and expects other categories to do slightly better.
    Show source
    Other than pain management, I think we are expecting 5 %, 6% growth, others should do slightly better.
  • The company expects pricing growth of around 2% to 3% in FY ’26.
    Show source
    Mohan Goenka: Should expect in similar lines, Harit, around 2% to 3%.
Show 22 more statements

What management expects

  • The company said costs were benign and might provide a slight benefit of 0.5 basis points, and it did not see margin pressure if prices remained at the same level.
    Show source
    And there might be slight benefit might be I think 0.5 basis points or something .
  • The company expected the contribution from new products to be in the range of 3%, depending on their success going ahead.
    Show source
    Rajesh Sharma: So it should be in the range of 3%, again depends on the success we get going ahead on that.
  • The company is targeting to ramp up growth at The Man Company this year by scaling marketplace share and quick commerce, revamping the brand and optimizing performance-based spend to drive profitability.
    Show source
    Similarly for The Man Company, we are targeting to ramp up growth this year, focused on scaling of marketplace share, quick commerce, a 360 revamp, and performance based spend optimization to drive profitability.
  • The company expects a gradual pickup in consumption, supported by easing inflation, recent income tax benefits to individual taxpayers, higher government CAPEX and a more accommodative monetary policy, including potential rate cuts.
    Show source
    We expect a gradual pickup in consumption, supported by easing inflation , recent income tax benefits to individual taxpayers, higher government CAPEX and a more accommodative monetary policy, including potential rate cuts.
  • The long-term target is for The Man Company and other startup brands to become profitable; profits are not expected immediately.
    Show source
    I am not expecting profits immediately, but of course the long term target is to get these brands to profitability.
  • Zairus Master’s mandate at The Man Company is to build a good team and restore its growth rate this year, with a long-term path to profitability.
    Show source
    And his mandate is essentially to be able to build a good team, to restore simulating growth rate this year itself.
  • A complete brand revamp is planned for The Man Company very soon.
    Show source
    There is a complete brand revamp which is planned very soon.
  • The company expects a slight challenge for its summer portfolio and will try to make it up with some of its other portfolios.
    Show source
    So there would be slight challenge on our summer portfolio, and we will try to see if we can make it up with some of our other portfolios.
  • The company plans to improve marketing campaigns and focus on better return on investment, considering shifts in consumer spending after COVID toward discretionary products and consumption outside the home, including restaurants and QSRs.
    Show source
    Going forward, we are going to drive improved marketing campaigns, focusing on a better return on investment, considering the fact that consumer shifts are also happening.
  • The company is focusing on categories beyond health supplements to drive incremental volume, market-share gains and overall growth, and plans to scale new product developments profitably, with more emphasis on consolidation and leveraging launches than in previous years.
    Show source
    So keeping these trends in mind, we are focusing on other categories besides health supplements which can drive incremental volume, market share gain and overall growth.
  • The company will undertake more initiatives in its medico business, including improved doctor connections and medico marketing, reaching more A-class doctors and focusing on therapies expected to provide higher returns.
    Show source
    We will also be doing a lot more initiatives on the Medico business by way of improved doctor connect, Medico marketing, and also reaching out to more A-class doctors, and focusing on certain therapies which should give us higher returns.
  • Kesh King strategy, prepared by BCG, is expected to roll out in the second quarter.
    Show source
    Hopefully we will be rolling out in the second quarter.
  • The company expects double-digit growth in healthcare.
    Show source
    Healthcare, we are very optimist of double-digit growth.
  • The company expected low single digit growth if some markets rebounded during the remaining four weeks of summer.
    Show source
    Let us hope if some markets rebound, then we might see low single digit growth.
  • The company expected mid singles growth to be achievable for talc, while repeating the base was a challenge; oil looked robust.
    Show source
    But having said that, mid singles should not be a problem, repeating the base is always tough, that's the current challenge we are having internally, oil so far looks robust.
  • The company planned to roll out other male grooming launches in Q2.
    Show source
    And on the other male grooming launches that we have planned for this year, we have plans in place, we will be rolling out in Q2.
  • The company planned launches in pain, male grooming and Kesh King D2C areas.
    Show source
    In pain I said there are a couple of launches planned, in mail grooming, in Kesh King also there are some D2C areas that we are going to come out with.
  • The company said it had identified opportunities for different offerings across E-com, quick-com, mass market and MT, to be rolled out quarter wise.
    Show source
    So it's like there are a lot of opportunities identified, which would all be rolled out quarter wise.
  • The targets for The Man Company and other startups are to restore growth and achieve substantial growth. Replaced by a later filing.
    Show source
    So, of course, the target is to get back to growth, to take The Man Company and other startups on the fast track , how can we get to substantial growth.
  • The company expects a significant rebound at The Man Company in the months to come. Replaced by a later filing.
    Show source
    So I expect a very significant rebound to happen in The Man Company in the months to come.
  • The company has a robust plan for new products in pain management. Replaced by a later filing.
    Show source
    But anyhow, we have a robust plan for new products in pain management.
  • The company expects growth for Smart and Handsome. Replaced by a later filing.
    Show source
    And of course we would see growth in this Smart and Handsome .

What it is building and selling

Demand and pricing

  • The company relaunched Smart and Handsome with a 360° plan that included changing the brand name, aggressive marketing and a go-to-market strategy in Q4.
    Show source
    So it was a well-planned rollout strategy for Smart and Handsome.

Segments

  • Pain management contributes around 20% of Emami’s overall revenues.
    Show source
    It almost contributes to around 20% of our overall revenues.
  • International business contributed almost 20% of its total revenue.
    Show source
    Mohan Goenka: We also have Vivek, who looks after international business and international now contributes to almost 20% of our total revenue.
  • Pain management segment includes Zandu Balm, Zandu Ultra Power and Mentho Plus Pain Balm.
    Show source
    One is Zandu Balm which is the mother brand, green color, and Zandu Ultra Power and Mentho Plus Pain Balm.
  • The company had introduced 25 new products this year, primarily Zandu Care. Replaced by a later filing.

Everything else said on the call

People and governance

  • Zairus Master joined The Man Company as Chief Executive Officer and Director.
    Show source
    We are very happy to inform that Mr. Zairus Master has joined as the Chief Executive Officer and Director at the Man Company.
  • Zairus Master previously served as Chief Business Officer at Honasa Consumer, where he managed brands including Mamaearth, The Derma Co., Aqualogica, Dr. Sheth’s and BBlunt.
    Show source
    In his most recent role as Chief Business Officer at Honasa Consumer, Zairus played a pivotal role in managing brands like Mamaearth, The Derma Co., Aqualogica, Dr. Sheth’s, and BBlunt.
  • The promoters have completely stepped away from The Man Company’s day-to-day operations, including their presence in the office.
    Show source
    The promoters have stepped away completely from day -to-day operations, including their presence in the office.
  • The original team’s departure and management volatility at The Man Company are behind the company. Replaced by a later filing.
    Show source
    As far as the original team is concerned and the volatility of management is concerned, I think that is behind us now.

What the company said on its earnings call, taken from its own transcript. Not advice.

Questions and answers

  1. Question

    Abhneesh Roy: Yes. Thanks and congrats on the good numbers. My first question is on Zairus Master, so here my question is, what will be his key KRA from the next two to three years’ perspective? In Man Company, in the past few quarters, your stake has almost become 100% and the numbers have been a bit volatile. And he has a excellent track record and excellent experience in Honasa, Unilever, Airtel, Nokia, etc . So what will be his main target over the next two to three years ’ timeframe in Man Company?

    Answer, mohan goenka

    Mohan Goenka: Yes, firstly, we are very excited to have him on board. We have been trying to reach out to him for quite some time. So this was absolutely part of our strategy to bring someone who understands this business very well. And of course , he has just joined a couple of weeks back, and he's a master in this. So, of course, the target is to get back to growth, to take The Man Company and other startups on the fast track , how can we get to substantial growth. Plus, at the same time, of course, the targets are to see that the brands get to profit in some time. I am not expecting profits immediately, but of course the long term target is to get these brands to profitability.

    Answer, mohan goenka

    These are the two goals what he has right now. Page 4 of 12 Emami Limited May 16, 2025 Abhneesh Roy: And one follow-up here, Man Company was also a D2C startup only.

  2. Question

    So in terms of now this new leadership and the overall performance has been a bit volatile. So, is the original team now fully gone? And in terms of anything weak in the business model, is there something weak or is it just the demand scenario which was weak, and the transition was there? Anything you can call out where there was a change needed in terms of strategy?

    Answer, giriraj bagri

    Giriraj Bagri: Yes. Thanks for the question. A couple of things. First, as Mohan ji mentioned, we are very excited to have the Zairus on board. And his mandate is essentially to be able to build a good team, to restore simulating growth rate this year itself. And also , a long-term path to profitability. As far as the original team is concerned and the volatility of management is concerned, I think that is behind us now.

    Answer, giriraj bagri

    The promoters have stepped away completely from day -to-day operations, including their presence in the office. So they are gone. There is a complete brand revamp which is planned very soon. So I expect a very significant rebound to happen in The Man Company in the months to come.

  3. Question

    Abhneesh Roy: Sir, my second question is on the cooling products, those have done quite well in Q4. My question is, in Q1 the base is high, because last year in Q1 you had done really well. What we are picking up in April and May, lot of the other cooling categories have not done well because there was all this sudden rains in North India, thundershower and temperature became low. So for example AC sales, the cooler sales and even the beverages, all those are have cooled off. So from that perspective, and high base, how do you see this category in Q1 see tough comparables in that scenario?

    Answer, mohan goenka

    Mohan Goenka: So Abhneesh, you are absolutely right. This quarter is slightly challenging as far as the summer portfolio is concerned. We saw a steep growth in Q4, so primaries happened. Unfortunately, southern markets and some parts of east and west have not done so well. So you are right, we are seeing sporadic rainfalls across India. So you are right, summer has seen a slight dent. I think let us wait for another two or three weeks, if we see some rebound, we have a higher base.

    Answer, mohan goenka

    So there would be slight challenge on our summer portfolio, and we will try to see if we can make it up with some of our other portfolios.

  4. Question

    Shirish Pardesi: Hi, Mohan ji and team. Thanks for the opportunity and congratulations. I was little bit excited seeing BoroPlus range has grown 27%. Did you see any sudden spike? I mean, winter was extended, but is there anything new which has happened in that segment? Page 5 of 12 Emami Limited May 16, 2025 Mohan Goenka: Not really, Shirish.

    Answer, mohan goenka

    When summer doesn't do so well, BoroPlus does slightly better and same trends is what we are seeing also in the first quarter, BoroPlus is doing, though it's a very, very small base, but April and May BoroPlus is shining better than our some of our summer items. So it is purely seasonal, honestly.

  5. Question

    Shirish Pardesi: Okay. The other thing I wanted to check with you, this Smart and Handsome launch has happened over the end of quarter or early, say, Jan?

    Answer, mohan goenka

    Mohan Goenka: Yes, we launched it in the second week of January. Shirish Pardesi: Okay. So by and large, we would have now phased out the Fair and Handsome and everything is getting replaced?

  6. Question

    Shirish Pardesi: Okay. The other question was, Pure and Glow, this is the entry into the Skin Care. What is the two, three timelines we should be monitoring for the next three to four quarters? I mean, yes, we are excited to see the new launch which has happened. But if you actually look at the skin care category with a lot of clutter less which is there, so what is it that we're talking different to the consumer?

    Answer, mohan goenka

    Mohan Goenka: Actually, every category is cluttered. So, of course, we have right out in larger categories , that is part of our growth strategy. And whitening is a big market, almost Rs. 3,000 crores, Rs. 4,000 crores market with monopoly of Lever. So we are talking it out in certain markets of South. Of course, it's based out of nature and science . We have some clinical results of 2 x brighter look plus extra moisturization. So let us see .

  7. Question

    Shirish Pardesi: And we are manufacturing ourselves or it is --?

    Answer, mohan goenka

    Mohan Goenka: No, it is in-house manufacturing.

  8. Question

    Shirish Pardesi: On the Brillare and TMC, though we now understand last year was consolidation and there were some hiccups. But over FY ’25 if I ask, FY ’26, how do you look at this business? I mean, obviously we have a business, and these all things will happen . But there are some aspirations what we have left when the consolidation happened. Page 6 of 12 Emami Limited May 16, 2025 Giriraj Bagri: Yes.

    Answer, giriraj bagri

    So when we look at FY ‘26, both for Brillare as well as for TMC, we are looking forward to a high double-digit growth in both these businesses. And there is a significant investment that we are making in both these businesses to build the brand franchise, especially the top of the funnel, as far as TMC and Brillare are concerned. And we are already seeing some green shoots when we look at certain channels and certain categories in the month of April and May. So , we should look forward to strong double-digit growth in FY ’26, both in Man Company and Brillare.

  9. Question

    Shirish Pardesi: But revenue if you can share.

    Answer, mohan goenka

    Mohan Goenka: We have excellent plans for healthcare. And Gul Raj is here, we have launched some significant brands in Zanducare and we have robust plans for healthcare growth. So Gul Raj, you can also pitch in and share some ideas, plans if you want for healthcare. Gul Raj Bhatia: So I think we have done fairly well in the healthcare portfolio, as indicated by Mr. Mohan ji, where they grew by 13% annualized. And it was led by three, four categories. One was the D2C portfolio Zanducare, which had a growth of nearly 50%, and it was led both by new product launches and various initiatives led by crude marketing, better return on investments in the marketing space, and also more aggressive claims in terms of our product benefits and efficacy. We also did well on some of the other categories in the portfolio in the OTC space.

    Answer, mohan goenka

    On brands like Nityam, brands like Cough Syrup where we grew in strong double digits along with the hair juices also. And on the medico business, which we reach out to doctors for, we had good growth there also, both in quarter four and for the whole year. Going forward, we are going to drive improved marketing campaigns, focusing on a better return on investment, considering the fact that consumer shifts are also happening. Post COVID consumers have by and large reduced spends on health supplements, immunity products, etc. And they are spending more on discretionary products, more on consumption outside the home in terms of restaurants, QSR's, etcetera. So keeping these trends in mind, we are focusing on other categories besides health supplements which can drive incremental volume, market share gain and overall growth. So, we will also be focused on NPDs, but I think the focus will be compared to previous years more on consolidating and leveraging the NPDs we launch to see how we are able to scale them up in a profitable Page 7 of 12 Emami Limited May 16, 2025 manner. We will also be doing a lot more initiatives on the Medico business by way of improved doctor connect, Medico marketing, and also reaching out to more A-class doctors, and focusing on certain therapies which should give us higher returns.

  10. Question

    Harit Kapoor: Yes. Good evening. I had a few questions. So one was, if you look at the pain management category for your business, it's been about seven quarters now of kind of single digit growth, obviously there was one de-growth quarter, but single digit kind of growth. Mostly from a slightly medium to long term perspective. is that the sort of trajectory that we should also kind of look at mid-single range, in a category that has got reasonable history, it should be kind of a normative growth? Or do you believe in any way innovations etc. can also kind of add a little bit more additional growth to this space? I ask because it's a high margin segment, so that was my first question.

    Answer, mohan goenka

    Mohan Goenka: Harit, you are right, pain management is an important segment for Emami. It almost contributes to around 20% of our overall revenues. And it has got three products. One is Zandu Balm which is the mother brand, green color, and Zandu Ultra Power and Mentho Plus Pain Balm. These are the three. Ultra Power and Mentho Plus has consistently been growing, but unfortunately the green pack, which is the main product, is showing signs of some stress. But anyhow, we have a robust plan for new products in pain management.

    Answer, mohan goenka

    We have launched a couple of products under this Zandu, and this year again we are launching one or two new offerings. So we are relying heavily on NPDs for growth in the pain portfolio.

Show 11 more questions
  1. Question

    Harit Kapoor: The second was a short one. This Smart and Handsome growth of 7%, is that indicative of the secondaries as well that retail level secondary growth is also 6%. 7%, 8%?

    Answer, mohan goenka

    Mohan Goenka: Absolutely. So after a long time we have seen some momentum in Smart and Handsome. You guys know that this band was continuously declining. And post the relaunch, we have arrested the de-growth. We are yet to see double digit growth what is targeted. But as I had mentioned earlier also that now this is a male grooming segment, it's not just the cream and the face wash. So you would see very extensive male grooming products coming under Smart and Handsome.

    Answer, mohan goenka

    And of course we would see growth in this Smart and Handsome . At the same time, I must say that the strategy for Kesh King is also ready by BCG. Hopefully we will be rolling out in the second quarter. So, by and large, I think we have addressed most of the issues, whether it is the Kesh King, The Man Company with Zairus we are very excited, with Page 8 of 12 Emami Limited May 16, 2025 Brillare also I think should grow. Smart and Handsome, the decline has been arrested. Healthcare, we are very optimist of double-digit growth. Other than pain management, I think we are expecting 5 %, 6% growth, others should do slightly better.

  2. Question

    Harit Kapoor: Got it. The last question was on price growth. So this quarter looks like a 3% type of growth at an overall level on pricing. So , just wanted your outlook on what should be kind of pricing growth assumption for F Y ’26? I know it's normally a 2% up and down a little bit, but just your sense on what it looks like for ’26?

    Answer, mohan goenka

    Mohan Goenka: Should expect in similar lines, Harit, around 2% to 3%.

  3. Question

    Ajay Thakur: Hi sir, thanks for taking my question. So sir, I had two questions. One was, just wanted to get a sense on the summer products, how the volume trajectory had been for both Navratna and the Dermicool, given the fact that their revenue growth has been pretty robust during the quarter? And also, if you can share some outlook for Q1 for the rest of the summer season?

    Answer, mohan goenka

    Mohan Goenka: This is a difficult one, Ajay. As I said, summer has not gone down so well, unfortunately. We had of course done some primaries in Q4 , so the secondaries are slightly on the lower side because of rains. So, we have yet another four weeks of summer left. Let us hope if some markets rebound, then we might see low single digit growth. Manish, do you want to add anything ? Manish Gupta is here, so Manish, if you want to add anything.

    Answer, mohan goenka

    Manish Gupta: Yes. So, all I will say is that from a Q4 perspective what the change we did in our strategy was to streamline how we load up that trade and everything. So, we have been very disciplined in our loading and the results are showing in Q4 Results, and both the primary and secondary part was very nice. April is where the pain point is, as we have been discussing, as the consumer offtakes have not been in line with the preparation that all the brands have done across the categories. And it is more pronounced in talc. Oil is there not so much impacted , talc is the one which is facing the heat. And within that, as Mohan ji mentioned earlier, it's south and parts of the lower Maharashtra and the parts of Odisha and all that.

    Answer, mohan goenka

    Now, from an outlook perspective all I can say is that talc is the one where we are right now keeping our fingers crossed. But having said that, mid singles should not be a problem, repeating the base is always tough, that's the current challenge we are having internally, oil so far looks robust. So, while we would have loved more, I would say that mid- singles still is not far away. Page 9 of 12 Emami Limited May 16, 2025 Ajay Thakur: Quite helpful, sir.

  4. Question

    Sir, the second question was more on the correction in the crude oil prices and we given that have some bit of a correlation with both LLP and the packaging cost , have you seen some benefit accruing in both these segments? And the outlook on the cost margin, that would be helpful.

    Answer, giriraj bagri

    Giriraj Bagri: So, Ajay, you have seen that our GCs have been at all-time high. And I have continuously been maintaining that I do not see any pressure on our GC s this year also. So , you are right, the costs are benign. And there might be slight benefit might be I think 0.5 basis points or something . So let us hope, let us see if the prices remain at the same level. Then we do not see any pressure on margins.

  5. Question

    Ajay Thakur: Understand. Thanks sir. Thanks for that.

    Answer, mohan goenka

    Mohan Goenka: We also have Vivek, who looks after international business and international now contributes to almost 20% of our total revenue. It's a significant large business for us. So Vivek, would you want to say anything on growth or our plans for anything you want to? Vivek Dhir: Sir, I think Bangladesh has improved quite a bit . When we had closed quarter three, we were in bit of trouble in line with industry over there. But Q4 we had seen a rebound , then we were still okay, February, March, we delivered very good numbers over there. GCC is still showing some signs of the growth and everything.

    Answer, mohan goenka

    Russia CIS is also decent for us. The only place of trouble is one or two countries in Africa which are decent for us, but by and large more places we are seeing more growth numbers over here.

  6. Question

    Percy Panthaki: Hi sir. Very glad to see Fair and Handsome back in positive territory. Can you give some more detail on exactly what was the work that went behind turning this brand around and sort of getting this performance back?

    Answer, mohan goenka

    Mohan Goenka: So Percy, it was all round 360 ° plan, right from changing the brand name to very aggressive marketing, both urban, rural, TV, OTT, digital, so everything. I think in Q4 we went very aggressive on go to market strategy. So it was a well-planned rollout strategy for Smart and Handsome. We hope that the momentum continues, that is what we are seeing. We are more optimistic on the face wash category because that is a very fast-growing category. And on the other male grooming launches that we have planned for this year, we have plans in place, we will be rolling out in Q2. So, we have been working for the last two years now and you would see some aggressive plans for this year for Smart and Handsome.

  7. Question

    Sir, has there been any change in formulation along with the relaunch?

    Answer, mohan goenka

    Mohan Goenka: Minute tweaks happen Percy, which is in line with what the consumer needs are. So, that is what it is. But overall I can say, the overall strategy what we have been planning for quite some time now has done well. Other than some dent in summer, I think most of the brands are in a very strong position. As far as manpower is concerned, with Zairus coming in, I think that is complete now. Second quarter, as I said, we will be rolling out with the strategy on Kesh King which is recommended. So with that, I think more or less all our brands relaunches are done.

    Answer, mohan goenka

    So we are going aggressive on advertising. We have done almost I think more than Rs. 690 crores of advertising this year, which is quite significant. And we will continue with that this year. That's it. I think if summers fares well for the next four weeks, hopefully we will see some good numbers.

  8. Question

    Percy Panthaki: Got it, sir. Just another question is on your innovation rate, what is the contribution of new products for this fiscal FY ‘25 that is just closed? And what would that similar number be targeted at for FY ‘26?

    Answer, rajesh sharma

    Rajesh Sharma: So roughly it is around 4% kind of revenue what we have generated from the products launched in last two to three years.

  9. Question

    Percy Panthaki: And will it similar going ahead or?

    Answer, rajesh sharma

    Rajesh Sharma: So it should be in the range of 3%, again depends on the success we get going ahead on that.

  10. Question

    Percy Panthaki: Got it. And what is the thought process in terms of any new product launch, or not new product but I would say any adjacencies, any new categories that you want to get into? I mean, you did mention that in Smart and Handsome it would be a broader male grooming place, so I am assuming some more subcategories would get launched there . But apart from that, do you think that your product portfolio is complete apart from the usual sort of variant thing, innovation, renovation that goes on in any FMCG company? Or would you like to enter any adjacent subcategories over the next two, three years?

    Answer, mohan goenka

    Mohan Goenka: So Percy, that is never complete. There are a lot of opportunities in Zandu. In pain I said there are a couple of launches planned, in mail grooming, in Kesh King also there are some D2C areas that we are going to come out with. This year itself we came with 25 new products, primarily Zandu Care. So this NPD momentum would continue. It is now a different strategy altogether for E-com, quick-com, they are very different offerings, for mass market there are different offerings, for MT t here are different offerings. So it's like there are a lot of opportunities identified, which would all be rolled out quarter wise.

  11. Question

    Percy Panthaki: Got it, got it sir. So just announce it once and if nobody comes up then we can close the call. Page 11 of 12 Emami Limited May 16, 2025 Rajesh Sharma: Thank you all.

    Answer, rajesh sharma

    Thank you all for joining our Q4 conference call. And thank you IIFL, thank you Percy for arranging this for us. Good day.

Questions about this call

When was the Emami Q4 FY25 earnings call transcript filed?
Emami filed the transcript with the exchange on 19 May 2025. This page is built from that transcript.
What does this page list?
51 statements from the transcript across 5 topics, 18 of them with a figure. Each statement is shown with the transcript sentence it came from.
Are the analysts' questions included?
Yes. 21 questions and management's answers are listed in the order they were asked, as the transcript prints them.
Who wrote this page?
DalalOS Data Desk. Assembled by software from the company's transcript. Not reviewed by a person. How it is made, and what it leaves out, is on the method page linked from the byline.
Research and analysis only, not investment advice. Every statement on this page is the company's own, taken from its transcript; DalalOS adds no view on it and is not a SEBI-registered investment adviser. Something wrong? Report an error.
Emami Q4 FY25 concall: Emami expects its market shares and household penetration across brands to support sustained growth in FY ‘26 · DalalOS